These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30310143)

  • 1. The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol.
    Vujanić GM; Gessler M; Ooms AHAG; Collini P; Coulomb-l'Hermine A; D'Hooghe E; de Krijger RR; Perotti D; Pritchard-Jones K; Vokuhl C; van den Heuvel-Eibrink MM; Graf N;
    Nat Rev Urol; 2018 Nov; 15(11):693-701. PubMed ID: 30310143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol.
    van den Heuvel-Eibrink MM; Hol JA; Pritchard-Jones K; van Tinteren H; Furtwängler R; Verschuur AC; Vujanic GM; Leuschner I; Brok J; Rübe C; Smets AM; Janssens GO; Godzinski J; Ramírez-Villar GL; de Camargo B; Segers H; Collini P; Gessler M; Bergeron C; Spreafico F; Graf N;
    Nat Rev Urol; 2017 Dec; 14(12):743-752. PubMed ID: 29089605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.
    Brok J; Lopez-Yurda M; Tinteren HV; Treger TD; Furtwängler R; Graf N; Bergeron C; van den Heuvel-Eibrink MM; Pritchard-Jones K; Olsen ØE; de Camargo B; Verschuur A; Spreafico F
    Lancet Oncol; 2018 Aug; 19(8):1072-1081. PubMed ID: 29960848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dataset for the reporting of nephrectomy specimens for Wilms' tumour treated with preoperative chemotherapy: recommendations from the International Society of Paediatric Oncology Renal Tumour Study Group.
    Vujanić GM; D'Hooghe E; Vokuhl C; Collini P
    Histopathology; 2021 Nov; 79(5):678-686. PubMed ID: 33942359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How we approach paediatric renal tumour core needle biopsy in the setting of preoperative chemotherapy: A Review from the SIOP Renal Tumour Study Group.
    Jackson TJ; Brisse HJ; Pritchard-Jones K; Nakata K; Morosi C; Oue T; Irtan S; Vujanic G; van den Heuvel-Eibrink MM; Graf N; Chowdhury T;
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29702. PubMed ID: 35587187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to letter commenting on "Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)".
    ; van den Heuvel-Eibrink MM; Pritchard-Jones K; van Tinteren H; Graf N
    Eur J Cancer; 2015 May; 51(8):995-6. PubMed ID: 25840668
    [No Abstract]   [Full Text] [Related]  

  • 7. Unmet needs for relapsed or refractory Wilms tumour: Mapping the molecular features, exploring organoids and designing early phase trials - A collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meeting.
    Brok J; Mavinkurve-Groothuis AMC; Drost J; Perotti D; Geller JI; Walz AL; Geoerger B; Pasqualini C; Verschuur A; Polanco A; Jones KP; van den Heuvel-Eibrink M; Graf N; Spreafico F
    Eur J Cancer; 2021 Feb; 144():113-122. PubMed ID: 33341445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).
    van den Heuvel-Eibrink MM; van Tinteren H; Bergeron C; Coulomb-L'Hermine A; de Camargo B; Leuschner I; Sandstedt B; Acha T; Godzinski J; Oldenburger F; Gooskens SL; de Kraker J; Vujanic GM; Pritchard-Jones K; Graf N
    Eur J Cancer; 2015 Mar; 51(4):498-506. PubMed ID: 25592561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001.
    Hol JA; Lopez-Yurda MI; Van Tinteren H; Van Grotel M; Godzinski J; Vujanic G; Oldenburger F; De Camargo B; Ramírez-Villar GL; Bergeron C; Pritchard-Jones K; Graf N; Van den Heuvel-Eibrink MM
    PLoS One; 2019; 14(8):e0221373. PubMed ID: 31425556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paediatric renal tumours: perspectives from the SIOP-RTSG.
    SIOP Renal Tumour Study Group
    Nat Rev Urol; 2017 Jan; 14(1):3-4. PubMed ID: 27922041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experience.
    Hol JA; Jongmans MCJ; Sudour-Bonnange H; Ramírez-Villar GL; Chowdhury T; Rechnitzer C; Pal N; Schleiermacher G; Karow A; Kuiper RP; de Camargo B; Avcin S; Redzic D; Wachtel A; Segers H; Vujanic GM; van Tinteren H; Bergeron C; Pritchard-Jones K; Graf N; van den Heuvel-Eibrink MM;
    Cancer; 2021 Feb; 127(4):628-638. PubMed ID: 33146894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Position paper: Rationale for the treatment of children with CCSK in the UMBRELLA SIOP-RTSG 2016 protocol.
    Gooskens SL; Graf N; Furtwängler R; Spreafico F; Bergeron C; Ramírez-Villar GL; Godzinski J; Rübe C; Janssens GO; Vujanic GM; Leuschner I; Coulomb-L'Hermine A; Smets AM; de Camargo B; Stoneham S; van Tinteren H; Pritchard-Jones K; van den Heuvel-Eibrink MM;
    Nat Rev Urol; 2018 May; 15(5):309-319. PubMed ID: 29485128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is radiotherapy required in first-line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP-RTSG, AIEOP, JWiTS, and UKCCSG.
    Fajardo RD; van den Heuvel-Eibrink MM; van Tinteren H; Spreafico F; Acha T; Bergeron C; de Camargo B; Oldenburger F; Rübe C; Oue T; Vokuhl C; de Krijger RR; Vujanic G; Sebire N; Coulomb-L'Hermine A; Collini P; Gandola L; Pritchard-Jones K; Graf N; Janssens GO; van Grotel M
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28039. PubMed ID: 31625685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult Wilms tumour.
    Zdrojowy R; Sawicz-Birkowska K; Apoznański W; Patkowski D; Szydełko T; Pietras W; Dembowski J
    Int Urol Nephrol; 2011 Sep; 43(3):691-6. PubMed ID: 21110097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Number of lymph nodes sampled in SFCE/SIOP 2001 patients with Wilms tumour: Is the goal of more than six achievable?
    Irtan S; Coulomb-Lhermine A; Lanz C; Tabone MD; Pasqualini C; Dumont B; Thebaud E; Guellec I; Verschuur A
    Pediatr Blood Cancer; 2023 Mar; 70(3):e30107. PubMed ID: 36453594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood.
    Vujanić GM; Sandstedt B; Harms D; Kelsey A; Leuschner I; de Kraker J;
    Med Pediatr Oncol; 2002 Feb; 38(2):79-82. PubMed ID: 11813170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients.
    Hontecillas-Prieto L; Garcia-Dominguez DJ; Vaca DP; Garcia-Mejias R; Marcilla D; Ramirez-Villar GL; Saez C; de Álava E
    Oncotarget; 2017 Feb; 8(7):11173-11186. PubMed ID: 28061436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocols.
    Groenendijk A; van Tinteren H; Jiang Y; de Krijger RR; Vujanic GM; Godzinski J; Rübe C; Schenk JP; Morosi C; Pritchard-Jones K; Al-Saadi R; Vaidya SJ; Verschuur AC; Ramírez-Villar GL; Graf N; de Camargo B; Drost J; Perotti D; van den Heuvel-Eibrink MM; Brok J; Spreafico F; Mavinkurve-Groothuis AMC
    Eur J Cancer; 2022 Mar; 163():88-97. PubMed ID: 35042071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).
    Green DM
    Eur J Cancer; 2015 May; 51(8):993-4. PubMed ID: 25818548
    [No Abstract]   [Full Text] [Related]  

  • 20. Wilms tumour: prognostic factors, staging, therapy and late effects.
    Kaste SC; Dome JS; Babyn PS; Graf NM; Grundy P; Godzinski J; Levitt GA; Jenkinson H
    Pediatr Radiol; 2008 Jan; 38(1):2-17. PubMed ID: 18026723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.